IQSEC1 Knockout HeLa Polyclonal Cells consist of a population of HeLa cells subjected to CRISPR/Cas9-mediated disruption of the IQSEC1 gene, generating a loss-of-function model for this guanine nucleotide exchange factor. This polyclonal knockout pool provides a heterogeneous collection of edited alleles, enabling the study of IQSEC1 deficiency without clonal isolation or monoclonality claims. Researchers can utilize these knockout cells to interrogate the cellular consequences of impaired IQSEC1 activity in a well-characterized human cervical epithelial adenocarcinoma background.
HeLa cells are a widely employed immortalized cell line derived from a cervical adenocarcinoma, retaining HPV18 genomic integration and stable proliferation characteristics. These adherent cells serve as a robust platform for studying adhesion, migration, and membrane trafficking processes, and offer experimental consistency across assays. Their human origin also ensures appropriate post-translational modifications and protein interaction networks relevant to oncogenic and developmental pathways.
IQSEC1 encodes a guanine nucleotide exchange factor that specifically activates ARF6, a small GTPase coordinating membrane trafficking and actin dynamics. Upon integrin engagement, IQSEC1 is recruited to adhesion sites and regulated by Src family kinases, bridging extracellular matrix signals to intracellular remodeling. It interacts with ??3 integrin, talin, and paxillin, and further associates with the AP-2 complex to facilitate ??1-integrin recycling. Downstream, IQSEC1-mediated ARF6 activation promotes Rac1 signaling and cofilin-dependent actin polymerization, thereby controlling cell spreading and directional migration. Extracellular signals such as P2Y purinergic receptor stimulation can also modulate this pathway.
In HeLa cells, IQSEC1 knockout disrupts integrin-mediated adhesion dynamics and focal adhesion turnover, making this model valuable for dissecting mechanisms of cancer cell migration and invasion. Given the role of IQSEC1 in neurodevelopmental disorders and intellectual disability, these cells also support studies on the conserved molecular functions of IQSEC1 outside neuronal lineages. The loss of IQSEC1 in a cervical carcinoma context allows direct assessment of ARF6-dependent trafficking events that contribute to metastatic potential.
These polyclonal knockout cells are suitable for a wide range of functional assays, including western blotting to confirm loss of IQSEC1 protein, cell adhesion and spreading assays to evaluate integrin-dependent attachment, transwell migration assays to measure chemotactic motility, and integrin recycling assays to monitor ARF6-regulated trafficking. Co-immunoprecipitation experiments can also probe altered interactions with talin, paxillin, or the AP-2 complex. This product is ideal for advanced research in cancer metastasis, membrane trafficking, and neurodevelopmental disease modeling. For more information, please contact Ascent Research.
